ライフサイエンスコーパス: adenosine monophosphate

1 n other cells by releasing a compound called adenosine monophosphate.

2 toxin fails to increase intracellular cyclic adenosine monophosphate.

3 iphosphate (ATP) to adenosine diphosphate or adenosine monophosphate.

4 a phosphate donor or a precursor for cyclic adenosine monophosphate.

5 xchange protein directly activated by cyclic adenosine monophosphate 1 (EPAC1)-RAP1-dependent model o

6 e nucleotide signaling molecule 3',5'-cyclic adenosine monophosphate (3',5'-cAMP) plays important phy

7 e stimulation of A2a receptors causes cyclic adenosine monophosphate accumulation at the back of cell

8 s of adiponectin receptor-2, inactivation of adenosine monophosphate activated protein kinase (AMPK),

9 malian target-of-rapamycin (mTOR) kinase and adenosine monophosphate activated protein kinase (AMPK).

10 th DENV activates the metabolic regulator 5' adenosine-monophosphate activated kinase (AMPK), and tha

11 s rescued by an activator of the Lkb1 target adenosine monophosphate-activated kinase (AMPK), pancrea

12 UDCA activates SMILE gene expression through adenosine monophosphate-activated kinase phosphorylation

13 oxamide-1-beta-d-ribofuranoside) to activate adenosine monophosphate-activated kinase resulted in TGF

14 d kinase) enzyme, which belongs to the AMPK (adenosine monophosphate-activated kinase) family, was es

15 The data suggest an adenosine monophosphate-activated kinase-dependent gain

16 promoter activity and gene expression in an adenosine monophosphate-activated kinase-dependent manne

17 Adenosine monophosphate-activated protein (AMP)-activate

18 5'-Adenosine monophosphate-activated protein kinase (AMPK)

19 Adenosine monophosphate-activated protein kinase (AMPK)

20 that regulates metabolism and growth through adenosine monophosphate-activated protein kinase (AMPK)

21 hat this response does not require canonical adenosine monophosphate-activated protein kinase (AMPK)

22 at the antidiabetes drug metformin (MET), an adenosine monophosphate-activated protein kinase (AMPK)

23 ver kinase B1 (LKB1, STK11) signaling via 5'-adenosine monophosphate-activated protein kinase (AMPK)

24 We investigated whether aspirin affects adenosine monophosphate-activated protein kinase (AMPK)

25 ular stores, which induces the activation of adenosine monophosphate-activated protein kinase (AMPK)

26 Adenosine monophosphate-activated protein kinase (AMPK)

27 The antitumor activities of the novel adenosine monophosphate-activated protein kinase (AMPK)

28 we identify a previously unexpected role for adenosine monophosphate-activated protein kinase (AMPK)

29 The activity of the metabolic sensor adenosine monophosphate-activated protein kinase (AMPK)

30 5'-Adenosine monophosphate-activated protein kinase (AMPK)

31 Loss of LKB1-adenosine monophosphate-activated protein kinase (AMPK)

32 Adenosine monophosphate-activated protein kinase (AMPK)

33 Adenosine monophosphate-activated protein kinase (AMPK)

34 tion while activating "stress" signals of 5' adenosine monophosphate-activated protein kinase (AMPK)

35 in high-altitude populations is one for the adenosine monophosphate-activated protein kinase (AMPK)

36 Adenosine monophosphate-activated protein kinase (AMPK)

37 antagonized the catalytic alpha1 subunit of adenosine monophosphate-activated protein kinase (AMPK),

38 nvolved in energy stress response, including adenosine monophosphate-activated protein kinase (AMPK),

39 aspirin at high doses, salicylate activates adenosine monophosphate-activated protein kinase (AMPK),

40 opsies were analyzed to assess changes in 5' adenosine monophosphate-activated protein kinase (AMPK),

41 are primary factors in the activation of 5'-adenosine monophosphate-activated protein kinase (AMPK),

42 ulate in cells exposed to stress, potentiate adenosine monophosphate-activated protein kinase (AMPK),

43 The increase in the ROS level activated 5' adenosine monophosphate-activated protein kinase (AMPK),

44 et of the peptide via modulation of upstream adenosine monophosphate-activated protein kinase (AMPK)-

45 mechanistic target of rapamycin (mTOR), and adenosine monophosphate-activated protein kinase (AMPK)-

46 competent up to p-Akt activation; however, p-adenosine monophosphate-activated protein kinase (p-AMPK

47 e induction of trained immunity, whereas the adenosine monophosphate-activated protein kinase activat

48 enosine triphosphate-citrate lyase inhibitor/adenosine monophosphate-activated protein kinase activat

49 ition, we showed that SNF5 knockdown induces adenosine monophosphate-activated protein kinase activat

50 Ex vivo experiments demonstrated that adenosine monophosphate-activated protein kinase activat

51 kinases 1/2, phosphatase and tensin homolog, adenosine monophosphate-activated protein kinase alpha,

52 hich controls IEB permeability by inhibiting adenosine monophosphate-activated protein kinase and inc

53 regulates IEB permeability by inhibiting an adenosine monophosphate-activated protein kinase and inc

54 displayed enhanced levels of phosphorylated adenosine monophosphate-activated protein kinase and its

55 (PTEN) induces activation of the phospho-5' adenosine monophosphate-activated protein kinase and pho

56 adou et al. report that the metabolic sensor adenosine monophosphate-activated protein kinase influen

57 hate-activated protein kinase, total protein adenosine monophosphate-activated protein kinase levels,

58 However, it activates adenosine monophosphate-activated protein kinase only in

59 d association with nitric oxide synthase and adenosine monophosphate-activated protein kinase pathway

60 Inhibition of 5'-adenosine monophosphate-activated protein kinase phospho

61 use adenosine triphosphate-citrate lyase and adenosine monophosphate-activated protein kinase play ce

62 Cardiac mitochondrial dysfunction and adenosine monophosphate-activated protein kinase seem as

63 rectly targets the 3' untranslated region of adenosine monophosphate-activated protein kinase subunit

64 However, the level of total adenosine monophosphate-activated protein kinase was sev

65 -dependent phosphorylation of distinct AMPK (adenosine monophosphate-activated protein kinase) family

66 cAMP-response element binding, p38 MAPK and adenosine monophosphate-activated protein kinase) in way

67 f ATM (ataxia telangiectasia mutated)/PRKAA (adenosine monophosphate-activated protein kinase) signal

68 NK1/2, p38 mitogen-activated protein kinase, adenosine monophosphate-activated protein kinase, and nu

69 which represses mTOR signaling by activating adenosine monophosphate-activated protein kinase, has be

70 response, leading to decreased activation of adenosine monophosphate-activated protein kinase, total

71 ng from the master energy-regulating kinase, adenosine monophosphate-activated protein kinase, while

72 Genes near adenosine monophosphate-activated protein kinase-alpha1

73 lmodulin-dependent kinase kinase-beta and 5' adenosine monophosphate-activated protein kinase-depende

74 hosphate-citrate lyase and the activation of adenosine monophosphate-activated protein kinase.

75 lation levels of signal transducer Stat3 and adenosine monophosphate-activated protein kinase.

76 Here we found that the energy-sensing adenosine-monophosphate-activated protein kinase (AMPK)

77 We investigated 5'-adenosine monophosphate (AMP) and 5'-uridine monophospha

78 Extra-cellular levels of adenosine monophosphate (AMP) and adenosine in porcine t

79 ediates AMPylation, a covalent attachment of adenosine monophosphate (AMP) from ATP to hydroxyl side

80 Generation of adenosine monophosphate (AMP) in blood is driven by cell

81 es gambiae efficiently converts adenosine to adenosine monophosphate (AMP) in the presence of guanosi

82 transcription factor 2 (ATF2) to the cyclic adenosine monophosphate (AMP) response element (CRE) in

83 In eukaryotes, cellular levels of adenosine monophosphate (AMP) signal the metabolic state

84 l modification that involves the addition of adenosine monophosphate (AMP) to a protein.

85 dence strongly indicated that it can convert adenosine monophosphate (AMP) to adenosine.

86 ently discovered to catalyze the addition of adenosine monophosphate (AMP) to Rho GTPases.

87 fficking in eukaryotic cells, by transfer of adenosine monophosphate (AMP) to Tyr(77).

88 Adenosine monophosphate (AMP) was used as a model compou

89 idly hydrolyzed by the ecto-ATPase CD39 into adenosine monophosphate (AMP), and it is AMP that regula

90 oxamide ribonucleotide (AICAR), an analog of adenosine monophosphate (AMP), in endotoxin-induced uvei

91 e (APT1), an enzyme that converts adenine to adenosine monophosphate (AMP), indicating a link between

92 ve catabolites: adenosine diphosphate (ADP), adenosine monophosphate (AMP), inosine monophosphate (IM

93 precursors, adenosine diphosphate (ADP) and adenosine monophosphate (AMP), using mouse heart, kidney

94 ow expression of SIRT1 and PGC1alpha and low adenosine monophosphate (AMP)-activated kinase (AMPK) ac

95 The adenosine monophosphate (AMP)-activated protein kinase (

96 longed metformin treatment on phosphorylated adenosine monophosphate (AMP)-activated protein kinase (

97 ly member 15 (TNFSF15) are upregulated by 5' adenosine monophosphate (AMP)-activated protein kinase (

98 3'-kinase/Akt pathway, is antagonized by the adenosine monophosphate (AMP)-activated protein kinase (

99 We found that the energy-sensing adenosine monophosphate (AMP)-activated protein kinase (

100 As adenosine monophosphate (AMP)-activated protein kinase b

101 s of RNA, depth for two nucleotides, and the adenosine monophosphate (AMP)-binding pocket at the bott

102 Acute pharmacological activation of adenosine monophosphate (AMP)-kinase using 5-aminoimidaz

103 se-, and triose-phosphates, UDP-glucose, and adenosine monophosphate (AMP).

104 1 and then AMPylates it by covalently adding adenosine monophosphate (AMP).

105 tivated by glucose 6-phosphate (Glc-6-P) and adenosine monophosphate (AMP).

106 hate (ATP), adenosine diphosphate (ADP), and adenosine monophosphate (AMP); and antioxidants, the sum

107 ients with genetic defects of the cyclic (c) adenosine-monophosphate (AMP)-signaling pathway and thos

108 iphosphate [ATP]/adenosine diphosphate [ADP]/adenosine monophosphate [AMP], nicotinamide adenine dinu

109 Glucagon and a cyclic adenosine monophosphate analog increased promoter activi

110 te its transcription in response to a cyclic adenosine monophosphate analog.

111 enzyme involved in the regulation of cyclic adenosine monophosphate and cyclic guanosine monophospha

112 regulate the intracellular levels of cyclic adenosine monophosphate and cyclic guanosine monophospha

113 culture and decidualized with 8-bromo-cyclic adenosine monophosphate and medroxyprogesterone acetate.

114 They are comprised of two mononucleotides, adenosine monophosphate and nicotinamide mononucleotide,

115 Nucleotide (ATP, adenosine diphosphate, adenosine monophosphate) and nucleoside (adenosine and i

116 Structures of adenosine monophosphate- and DNA- bound M2-1 establish t

117 In 3,5-cyclic adenosine monophosphate assays, the novel series behaved

118 ly, we demonstrate that Akt up-regulates the adenosine monophosphate-associated kinase (AMPK)-related

119 Strikingly, the measured on-rate for cyclic adenosine monophosphate binding is two orders of magnitu

120 Cyclic adenosine monophosphate binding not only unleashes activ

121 educed renal ATP, adenosine diphosphate, and adenosine monophosphate, but not adenosine levels, durin

122 Cyclic di-adenosine monophosphate (c-di-AMP) is a broadly conserve

123 Cyclic di-3',5'-adenosine monophosphate (c-di-AMP) is a broadly conserve

124 Cyclic di-adenosine monophosphate (c-di-AMP) is a widely distribut

125 Cyclic di-adenosine monophosphate (c-di-AMP) is an important secon

126 The nucleotide cyclic di-3',5'- adenosine monophosphate (c-di-AMP) was recently identifi

127 Detection of cyclic-di-adenosine monophosphate (c-di-AMP), a bacterial second m

128 n ADCY5 was studied by measurement of cyclic adenosine monophosphate (cAMP) accumulation under stimul

129 l had an impaired capacity to degrade cyclic adenosine monophosphate (cAMP) and a blunted pharmacolog

130 mediated initially by an increase in cyclic adenosine monophosphate (cAMP) and a subsequent inactiva

131 Diminished cyclic adenosine monophosphate (cAMP) and augmented cyclic guan

132 The cyclic adenosine monophosphate (cAMP) and Ca(2+) signaling path

133 Cyclic adenosine monophosphate (cAMP) and cyclic guanosine mono

134 lation of the intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine mono

135 Cyclic adenosine monophosphate (cAMP) and protein kinase A (PKA

136 kar1a(+/-)), the primary receptor for cyclic adenosine monophosphate (cAMP) and regulator of protein

137 s contributed to an increase in basal cyclic adenosine monophosphate (cAMP) and vasodilator-stimulate

138 In 3,5-cyclic adenosine monophosphate (cAMP) assays, the novel series

139 In 3,5-cyclic adenosine monophosphate (cAMP) assays, the novel series

140 prostaglandin E1-induced increase in cyclic adenosine monophosphate (cAMP) by ADP was impaired, wher

141 udies exploring the importance of the cyclic adenosine monophosphate (cAMP) cascade in major depressi

142 (PDE4), an important component of the cyclic adenosine monophosphate (cAMP) cascade, selectively meta

143 bunit through formation of a PDE-PKAR-cyclic adenosine monophosphate (cAMP) complex (the termination

144 Cyclic adenosine monophosphate (cAMP) drives genetic polycystic

145 Elevation of cyclic adenosine monophosphate (cAMP) following cell detachment

146 phodiesterase (PDE4) and elevation of cyclic adenosine monophosphate (cAMP) has emerged as a promisin

147 s associated with increased levels of cyclic adenosine monophosphate (cAMP) in cholangiocytes lining

148 hnology have revealed oscillations of cyclic adenosine monophosphate (cAMP) in insulin-secreting cell

149 centration of the secondary messenger cyclic adenosine monophosphate (cAMP) in MLT cells, in response

150 d to do so by only D1 receptor-driven cyclic adenosine monophosphate (cAMP) increases or D2 receptor-

151 rom the canalicular membrane, whereas cyclic adenosine monophosphate (cAMP) increases plasma membrane

152 Cyclic 3',5'-adenosine monophosphate (cAMP) is a critical and ubiquit

153 3',5'-Cyclic adenosine monophosphate (cAMP) is a pivotal second messe

154 Cyclic adenosine monophosphate (cAMP) is a second messenger wit

155 Cyclic adenosine monophosphate (cAMP) is an important mediator

156 Cyclic adenosine monophosphate (cAMP) is an important mediator

157 Cyclic adenosine monophosphate (cAMP) is very important in the

158 and kidney (PKD) diseases, increased cyclic adenosine monophosphate (cAMP) levels trigger hepatorena

159 Intracellular cyclic adenosine monophosphate (cAMP) levels tune the voltage r

160 In contrast, basal cyclic adenosine monophosphate (cAMP) levels, agonist-stimulate

161 ds such as elevation of intracellular cyclic adenosine monophosphate (cAMP) levels, and depends on up

162 E17G increased cyclic adenosine monophosphate (cAMP) levels, and this increase

163 olin, both of which increase platelet cyclic adenosine monophosphate (cAMP) levels.

164 ts that raise intracellular Ca(2+) or cyclic adenosine monophosphate (cAMP) levels.

165 ding, Matrigel invasion and Galpha(i) cyclic adenosine monophosphate (cAMP) modulation signaling.

166 genetic analyses have identified the cyclic adenosine monophosphate (cAMP) pathway and a previously

167 udy was designed to examine whether a cyclic adenosine monophosphate (cAMP) phosphodiesterase (PDE),

168 ltures of LMMP neurons (PC-LMMPn) and cyclic adenosine monophosphate (cAMP) production in human embry

169 gation and morphogenesis by secreting cyclic adenosine monophosphate (cAMP) pulses that propagate as

170 Cyclic adenosine monophosphate (cAMP) regulates long-term poten

171 The transcription factor cyclic adenosine monophosphate (cAMP) response element binding

172 ond, we found that phosphorylation of cyclic adenosine monophosphate (cAMP) responsive-element-bindin

173 A (PKA) is the major receptor for the cyclic adenosine monophosphate (cAMP) secondary messenger in eu

174 erate spatial compartmentalization of cyclic adenosine monophosphate (cAMP) signaling at the centroso

175 demonstrate a differential effect of cyclic adenosine monophosphate (cAMP) signaling between normal

176 DISC1 also regulates cyclic adenosine monophosphate (cAMP) signaling by increasing t

177 Using a marker of the cyclic adenosine monophosphate (cAMP) signaling cascade and lip

178 We report here that cocaine and cyclic adenosine monophosphate (cAMP) signaling induce the tran

179 ell disease and activated through the cyclic adenosine monophosphate (cAMP) signaling pathway.

180 3 (PDE3) is an important regulator of cyclic adenosine monophosphate (cAMP) signaling within the card

181 duct ligation (BDL) by activation of cyclic adenosine monophosphate (cAMP) signaling.

182 ent increased intracellular levels of cyclic adenosine monophosphate (cAMP) that turned on protein ki

183 dent increases in secondary-messenger cyclic adenosine monophosphate (cAMP) to activate protein kinas

184 Binding of 3',5'-cyclic adenosine monophosphate (cAMP) to hyperpolarization-acti

185 or D1 (DRD1) via the second messenger cyclic adenosine monophosphate (cAMP) to synthetic promoters co

186 were treated with Angiopoietin 1 and cyclic adenosine monophosphate (cAMP) to vary the Pd of the HUV

187 In this study, we showed that cyclic adenosine monophosphate (cAMP) treatment induced DON pro

188 Levels of cyclic adenosine monophosphate (cAMP) were elevated over sustai

189 f phenylalanine, acetylhistidine, and cyclic adenosine monophosphate (cAMP) were found in urine sampl

190 Here we demonstrate that cyclic adenosine monophosphate (cAMP), a second messenger downs

191 Here we examine whether increases in cyclic adenosine monophosphate (cAMP), an intracellular signali

192 th a small molecule second messenger, cyclic adenosine monophosphate (cAMP), and a downstream cell-se

193 rchestrated by waves of extracellular cyclic adenosine monophosphate (cAMP), and previous theory sugg

194 s have implicated defective dopamine, cyclic adenosine monophosphate (cAMP), and Ras homeostasis.

195 MRE-269 increased intracellular 3',5'-cyclic adenosine monophosphate (cAMP), augmented glucose-stimul

196 The cyclic adenosine monophosphate (cAMP), mitogen-activated protei

197 Cyclic adenosine monophosphate (cAMP), when added, induces cyst

198 R reduced ability of SCT to stimulate cyclic adenosine monophosphate (cAMP), with signaling augmented

199 vated protein kinase (MAPK) and 3'-5'-cyclic adenosine monophosphate (cAMP)-associated signaling path

200 Here we studied the cyclic adenosine monophosphate (cAMP)-dependent gating in hyper

201 helial barrier can be up-regulated by cyclic adenosine monophosphate (cAMP)-dependent mechanisms thro

202 spatiotemporal signaling control, the cyclic adenosine monophosphate (cAMP)-dependent protein kinase

203 roach was applied to the prototypical cyclic adenosine monophosphate (cAMP)-dependent protein kinase

204 coding the gamma-catalytic subunit of cyclic adenosine monophosphate (cAMP)-dependent protein kinase

205 In its physiological state, cyclic adenosine monophosphate (cAMP)-dependent protein kinase

206 rmore, we demonstrated that Tregs use cyclic adenosine monophosphate (cAMP)-dependent protein kinase

207 )-dependent protein kinase C (PKC) or cyclic adenosine monophosphate (cAMP)-dependent protein kinase

208 Cyclic adenosine monophosphate (cAMP)-dependent signaling modul

209 Cyclic adenosine monophosphate (cAMP)-dependent signaling modul

210 Cyclic 3'5' adenosine monophosphate (cAMP)-dependent-protein kinase

211 motes beta cell Tcf7 expression via a cyclic adenosine monophosphate (cAMP)-independent and extracell

212 e aryl hydrocarbon receptor (AhR) and cyclic adenosine monophosphate (cAMP)-mediated signaling pathwa

213 odendritic domain, depends on ongoing cyclic adenosine monophosphate (cAMP)-protein kinase A (PKA) le

214 lation of the prostaglandin E2 (PGE2)-cyclic adenosine monophosphate (cAMP)-protein kinase A (PKA) si

215 tion of NMJ growth occurs through the cyclic adenosine monophosphate (cAMP)-protein kinase A (PKA)-cA

216 genetic deletion of HCN2 removed the cyclic adenosine monophosphate (cAMP)-sensitive component of I(

217 chemotaxis towards emitted pulses of cyclic adenosine monophosphate (cAMP).

218 on gradient of the signaling molecule cyclic adenosine monophosphate (cAMP).

219 d including increased levels of 3'-5'-cyclic adenosine monophosphate (cAMP).

220 a dramatic increase of intracellular cyclic adenosine monophosphate (cAMP).

221 o lead to the autonomous synthesis of cyclic adenosine monophosphate (cAMP).

222 P-ribose) polymerase 1 (PARP1) by the cyclic adenosine monophosphate (cAMP)/protein kinase A (PKA) sy

223 In polycystin-2 (PC2)-defective mice, cyclic adenosine monophosphate (cAMP)/protein kinase A (PKA)-de

224 by beta-adrenergic signaling through cyclic adenosine monophosphate (cAMP); however, the mechanism f

225 ntified as full antagonist ligands on cyclic adenosine monophosphate (cAMP, KB = 4.9 and 5.9 nM, resp

226 aling pathway function (Ras activity, cyclic adenosine monophosphate [cAMP], and dopamine levels).

227 lutamatergic, monoaminergic, calcium, cyclic adenosine monophosphate [cAMP], dopamine- and cAMP-regul

228 horylation of DARPP-32 (dopamine- and cyclic adenosine monophosphate [cAMP]-regulated phospho-protein

229 tification of cyclic guanosine monophosphate-adenosine monophosphate (cGAMP) synthase (cGAS) as a cyt

230 he DNA sensor cyclic guanosine monophosphate-adenosine monophosphate (cGAMP) synthase (cGAS) binds to

231 sis activated cyclic guanosine monophosphate-adenosine monophosphate (cGAMP) synthase (cGAS) in macro

232 ion activates cyclic guanosine monophosphate-adenosine monophosphate (cGAMP) synthase (cGAS) to produ

233 STING), 2'3'- cyclic guanosine monophosphate-adenosine monophosphate (cGAMP), robustly augmented and

234 STING ligand cyclic guanosine monophosphate-adenosine monophosphate (cGAMP), we stimulated periphera

235 Structural analysis of apo-BaMccF and its adenosine monophosphate complex reveals specific feature

236 s synthesized cyclic guanosine monophosphate-adenosine monophosphate (cyclic GMP-AMP, or cGAMP) in vi

237 production of cyclic guanosine monophosphate-adenosine monophosphate (cyclic GMP-AMP, or cGAMP), whic

238 rase 10A (PDE10A), a dual-specificity cyclic adenosine monophosphate/cyclic guanosine monophosphate-i

239 ve condition resulting from mutations in the adenosine monophosphate deaminase 2 gene (AMPD2).

240 ions that trigger the damage of large cyclic adenosine monophosphate-dependent cholangiocytes.

241 c adenosine monophosphate levels; and cyclic adenosine monophosphate-dependent protein kinase A-media

242 ng the gamma-catalytic subunit of the cyclic adenosine monophosphate-dependent protein kinase, the mu

243 PDGF-BB induced cyclic adenosine monophosphate-dependent protein kinase-depende

244 ivation of neuronal EP2 receptors and cyclic adenosine monophosphate-dependent protein kinase.

245 horylation of its headpiece domain by cyclic adenosine monophosphate-dependent protein kinase.

246 Optogenetic upregulation of cyclic adenosine monophosphate during the day increases sleep i

247 degraded into a mono-organophosphate (e.g., adenosine monophosphate) during heating.

248 AVP/cyclic adenosine monophosphate enhance the phosphorylation of t

249 antification of xanthosine monophosphate and adenosine monophosphate (for normalization) in lysates o

250 nylyl cyclase (AC) and an increase in cyclic adenosine monophosphate formation.

251 n channel hyperpolarization-activated cyclic adenosine monophosphate gated channel type 1 (HCN1) occu

252 We show that cyclic-di-adenosine monophosphate in live Gram-positive bacteria i

253 ores the suppressive effects of 3',5'-cyclic adenosine monophosphate in lymphocytes.

254 oreover, c-di-GMP, but not cyclic di-(3':5')-adenosine monophosphate, induced stalk gene expression i

255 Cyclic adenosine monophosphate-induced enteroid intracellular p

256 )-TOC demonstrated higher potency for cyclic adenosine monophosphate inhibition (half maximal effecti

257 is a key molecule, since via degradation of adenosine monophosphate into adenosine, endorses the gen

258 nase (PFK), lactate dehydrogenase (LDH), and adenosine monophosphate kinase (AMPK) were measured util

259 (GP)IIb/IIIa activation and decreased cyclic adenosine monophosphate levels (n = 6, P < .01) in plate

260 n of the cardiac stress marker NR4A1; cyclic adenosine monophosphate levels; and cyclic adenosine mon

261 phosphate (ATP) and adenosine diphosphate to adenosine monophosphate on NK cells, thereby modulating

262 n-activated protein kinase) and cAMP (cyclic adenosine monophosphate)-PKA (protein kinase A) cascades

263 at rolipram, an anti-inflammatory and cyclic adenosine monophosphate preserving small molecule, impro

264 (UPR), intracellular ion homeostasis, cyclic adenosine monophosphate production and regulation of ins

265 nosine uptake by red blood cells, and cyclic adenosine monophosphate production by cells overexpressi

266 teoclast differentiation by enhancing cyclic adenosine monophosphate production through an unidentifi

267 giocytes show increased production of cyclic adenosine monophosphate, protein kinase A-dependent acti

268 m of ICAM-4 activation occurs via the cyclic adenosine monophosphate-protein kinase A (cAMP-PKA)-depe

269 In PC2-defective mice, cyclic 3',5'-adenosine monophosphate/ protein kinase A (cAMP/PKA)-dep

270 therapy, which elevates intracellular cyclic adenosine monophosphate/protein kinase A (cAMP-PKA) sign

271 acyclin which stimulates the platelet cyclic adenosine monophosphate/protein kinase A (cAMP/PKA)-sign

272 Previous studies have implicated the cyclic adenosine monophosphate/protein kinase A pathway as well

273 ed the role of DARPP-32 (dopamine and cyclic adenosine monophosphate-regulated phosphoprotein, Mr 320

274 trophic factor and phosphorylation of cyclic adenosine monophosphate response element binding and neu

275 own that nuclear transcription factor cyclic adenosine monophosphate response element binding protein

276 ional activity and phosphorylation of cyclic adenosine monophosphate response element binding protein

277 es the levels of transcription factor cyclic adenosine monophosphate response element binding protein

278 ated the functional regulation of the cyclic adenosine monophosphate response element binding protein

279 expression of the binding protein of cyclic adenosine monophosphate response element binding protein

280 r regions of the transcription factor cyclic adenosine monophosphate response element-binding protein

281 ISC1 caused a significant increase of cyclic adenosine monophosphate response element-binding protein

282 tion and is required for signaling to cyclic adenosine monophosphate response element-binding protein

283 promoter region as well as increased cyclic adenosine monophosphate response element-mediated transc

284 The transcription factor, cyclic adenosine monophosphate-responsive element modulator alp

285 ranscription coupling caused by CREB (cyclic adenosine monophosphate-responsive element-binding prote

286 carboxylase-oxygenase (RuBisCO) that couples adenosine monophosphate salvage with CO(2) fixation, a p

287 he current study examined whether D1R-cyclic adenosine monophosphate signaling reduces neuronal firin

288 amine D1 receptor (D1R) activation of cyclic adenosine monophosphate signaling, which reduces PFC neu

289 cts of dopamine receptor D2 (DRD2) on cyclic adenosine monophosphate signaling; PDAC tissues had a sl

290 ed generation of the second messenger cyclic adenosine monophosphate, suggesting that alterations in

291 Cyclic guanosine monophosphate-adenosine monophosphate synthase (cGAS) detects intracel

292 he DNA sensor cyclic guanosine monophosphate-adenosine monophosphate synthase and the downstream adap

293 king STING or cyclic guanosine monophosphate-adenosine monophosphate synthase exhibit unaltered abili

294 n of alkaline phosphatase, which can convert adenosine monophosphate to adenosine.

295 Fic domains can catalyze the addition of adenosine monophosphate to target proteins.

296 well-studied system is the binding of cyclic adenosine monophosphate to the cyclic nucleotide binding

297 nt loss of worm motility dependent on cyclic adenosine monophosphate, whereas transient photoactivati

298 exchange factor directly activated by cyclic adenosine monophosphate, which maintains vascular integr

299 Increases in cyclic adenosine monophosphate with forskolin caused enteroid i

300 osine 3',5'-cyclic monophosphate, and cyclic adenosine monophosphate with reduced spreading on collag